Jay Moorin, 10% Owner at UroGen Pharma Ltd. (URGN), sold 418,596 shares at $40.51 ($17.0M) on 2017-11-28, disclosed to the SEC on 2017-11-29.
Open-market sale of $17.0M URGN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.12 | 31,491 | $1.3M | 7.6% |
| 2 | $41.12 | 31,491 | $1.3M | 7.6% |
| 3 | $40.51 | 177,807 | $7.2M | 42.4% |
| 4 | $40.51 | 177,807 | $7.2M | 42.4% |
| Total | $40.60 avg | 418,596 | $17.0M | 100% |
| Filing → |
| IMDZ | SELL | 2015-03-18 | $1.3M | — | Filing → |
| EGRX | BUY | 2014-02-20 | $5.0M | — | Filing → |
| ACHN | SELL | 2009-12-18 | $2.0M | — | Filing → |